David Graham, MPH, MD

Associate director
US Food and Drug Administration
Silver Spring, Maryland, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• Mortality Among Parkinson's Disease Patients Treated with Pimavanserin or Atypical Antipsychotics: An Observational Study in Medicare

  Saturday, August 27, 2022
  2:00 PM – 2:05 PM CEST

• Systemic Corticosteroids for COVID-19 in U.S. Outpatient Settings

  Sunday, August 28, 2022
  8:45 AM – 9:00 AM CEST